Cronos Group Inc. (CRON) vs Eton Pharmaceuticals, Inc. (ETON)

Cronos Group Inc. and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Cronos Group Inc. and Eton Pharmaceuticals, Inc. are of similar size ($1.4B and $1.4B). Cronos Group Inc. trades at the lower P/E: 21.9× against 26.8×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 100.6% against 55.8%. Eton Pharmaceuticals, Inc. has the higher net margin (35.4% vs 28.0%) and the higher return on invested capital (46.8% vs 1.28%). Across the 21 metrics below, Cronos Group Inc. leads on 11 and Eton Pharmaceuticals, Inc. on 10.

Valuation

Metric CRON ETON Drug Manufacturers Specialty & Generic median
P/E 21.88 26.81 20.55
P/S 6.65 9.64 2.08
P/B 1.22 15.65 1.79
Price to free cash flow 21.09 68.02 16.29
EV/EBITDA 26.94 28.65 12.22
EV/Sales 3.04 9.41 2.87
Earnings yield 4.57% 3.73% (15.94%)
Free cash flow yield 4.74% 1.47% 0.00%

Profitability

Metric CRON ETON Drug Manufacturers Specialty & Generic median
Gross margin 46.59% 69.15% 53.51%
Operating margin 3.78% 28.84% 0.00%
Net margin 28.04% 35.35% (2.45%)
Free cash flow margin 31.71% 14.17% 0.00%
Return on equity 5.12% 90.62% (0.80%)
Return on assets 4.87% 38.10% (1.67%)
Return on invested capital 1.28% 46.77% 0.00%

Growth

Metric CRON ETON Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 55.79% 100.61% 5.22%
EPS growth (last fiscal year) (118.18%) (13.33%) 42.91%
Revenue growth, 5-year CAGR 25.70% 359.57% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRON ETON Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.27 0.04
Current ratio 12.71 1.79 2.41
Net debt to EBITDA 337.10 1.18 1.01

Dividend

Metric CRON ETON Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CRON ETON Drug Manufacturers Specialty & Generic median
Market cap 1.37b 1.35b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack